Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: Design and rationale of the ROADMAP clinical trial
Joseph G. Rogers(Baylor College of Medicine), Randall C. Starling(Cleveland Clinic), Mark S. Slaughter(University of Louisville), Douglas Horstmanshof(INTEGRIS Baptist Medical Center), Donald Haas(Abington Memorial Hospital), David J. Farrar(Southwestern Medical Center), Andrew Boyle(Thomas Jefferson University), John B. OʼConnell(Thoratec Corporation (United States)), Soon J. Park(Mayo Clinic)
Cited by 33
Related Papers
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
|Circulation|2007|1k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure
|New England Journal of Medicine|2008|763
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711